⚠LCC is operating - we're just doing things differently.
Due to the ongoing pandemic, most programs and services are still operating remotely. Select "learn more" to access a list of face-to-face and hybrid classes for fall quarter. Applications for emergency funding assistance are still being accepted for fall quarter, which starts September 21. - Learn More.
It is the policy of the College to act in an ethically responsible manner when conducting research involving human subjects. To that end, an Institutional Review Board has been established to provide a process to ensure that the normal and prudent policies established for the protection of human subjects is followed at Lower Columbia College.
This policy applies to any and all research (i.e., activities that are procedures, demonstrations, and/or experiments which use human subjects) conducted by College faculty, staff, or students as well as to any non-College entities performing research upon College faculty, staff, or students with the expressed consent of the College. Persons conducting such research are known, for the purpose of this document, as investigators.
The basic principles adhered to by the College are drawn from the Belmont Report, written by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research in 1979.
The investigator shall present to the Institutional Review Board (IRB) a description of his or her research project's goals, objectives, and procedures to (Lower Columbia College: Institutional Review Board), along with documentation addressing each of the following (taken from the Ethics in Medicine at U of W.)
Disclosure: The potential participant must be as fully informed as possible of the nature and purpose of the research, the procedures to be used, and the expected benefits to the participant and/or society, the potential of reasonably foreseeable risks, stresses, and discomforts, and alternatives to participating in the research. There should also be a statement that describes procedures in place to ensure the confidentiality or anonymity of the participant. The informed consent document must also disclose what compensation and medical treatment are available in the case of a research-related injury. The document should make it clear whom to contact with questions about the research study, about research subjects' rights, and in case of injury.
Understanding: The participant must understand what has been explained and must be given the opportunity to ask questions and have them answered by one of the investigators. The informed consent document must be written in lay language, avoiding any technical jargon.
Voluntariness: The participant's consent to participate in the research must be voluntary, free of any coercion or promises of benefits unlikely to result from participation.
Competence: The participant must be competent to give consent. If the participant is not competent due to mental status, disease, or emergency, a designated surrogate may provide consent if it is in the best interest of the participant.
Consent: The potential human subject must authorize his/her participation in the research study, preferably in writing
Some research with human subjects is exempt from the requirements of this document if it meets the following criteria (taken from Belmont Report referenced above in 320.1).
Investigators must request approval for all proposed projects from the Institutional Review Board (IRB). The Institutional Review Board will consider all requests and may approve the project, decline to approve the project, or grant a Certificate of Exemption indicating that the criteria detailed in 320.3 has been met.